Literature DB >> 23218265

Preparation and characterization of nonaarginine-modified chitosan nanoparticles for siRNA delivery.

Soyeon Park1, Eun Ju Jeong, Jangwook Lee, Taiyoun Rhim, Sang Kyung Lee, Kuen Yong Lee.   

Abstract

Chitosan-based nanoparticles have been widely used as a carrier for gene delivery due to their low toxicity and the positively charged amino groups in chitosan. In this study, we hypothesized that introduction of nonaarginine to chitosan could improve its ability to form a complex with siRNA, as well as enhance the cellular uptake and transfection efficiency of chitosan-based nanoparticles. To this end, a peptide with nine repeating arginine residues was chemically coupled to the chitosan backbone, and various characteristics of nonaarginine-chitosan/siRNA nanoparticles were investigated. The mean diameter and zeta potential of the nonaarginine-chitosan/siRNA nanoparticles were dependent on the amount of nonaarginine conjugated to chitosan. Nonaarginine-modified chitosan/siRNA nanoparticles demonstrated enhanced cellular association and transfection efficiency in vitro, while maintaining a low level of cytotoxicity. In conclusion, nonaarginine-modified chitosan should be considered a potential carrier for various gene delivery applications.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23218265     DOI: 10.1016/j.carbpol.2012.08.116

Source DB:  PubMed          Journal:  Carbohydr Polym        ISSN: 0144-8617            Impact factor:   9.381


  12 in total

1.  Chitosan-based hybrid nanocomplex for siRNA delivery and its application for cancer therapy.

Authors:  Min-Hyo Ki; Ji-Eon Kim; Young-Nam Lee; Sang Myoung Noh; Sung-Won An; Hyun-Jong Cho; Dae-Duk Kim
Journal:  Pharm Res       Date:  2014-05-24       Impact factor: 4.200

2.  Glutamine-chitosan modified calcium phosphate nanoparticles for efficient siRNA delivery and osteogenic differentiation.

Authors:  Bogyu Choi; Zhong-Kai Cui; Soyon Kim; Jiabing Fan; Benjamin M Wu; Min Lee
Journal:  J Mater Chem B       Date:  2015-08-21       Impact factor: 6.331

Review 3.  Nanoparticle-mediated pulmonary drug delivery: a review.

Authors:  Mukta Paranjpe; Christel C Müller-Goymann
Journal:  Int J Mol Sci       Date:  2014-04-08       Impact factor: 5.923

Review 4.  Cell Penetrating Peptide Conjugated Chitosan for Enhanced Delivery of Nucleic Acid.

Authors:  Buddhadev Layek; Lindsey Lipp; Jagdish Singh
Journal:  Int J Mol Sci       Date:  2015-12-04       Impact factor: 5.923

5.  Chitosan-based nanoparticles for survivin targeted siRNA delivery in breast tumor therapy and preventing its metastasis.

Authors:  Ping Sun; Wei Huang; Mingji Jin; Qiming Wang; Bo Fan; Lin Kang; Zhonggao Gao
Journal:  Int J Nanomedicine       Date:  2016-09-27

6.  Targeted Delivery Prodigiosin to Choriocarcinoma by Peptide-Guided Dendrigraft Poly-l-lysines Nanoparticles.

Authors:  Kai Zhao; Dan Li; Guogang Cheng; Baozhen Zhang; Jinyu Han; Jie Chen; Baobei Wang; Mengxia Li; Tianxia Xiao; Jian Zhang; Dongpo Zhou; Zheng Jin; Xiujun Fan
Journal:  Int J Mol Sci       Date:  2019-11-01       Impact factor: 5.923

Review 7.  Chitin, chitosan, and glycated chitosan regulate immune responses: the novel adjuvants for cancer vaccine.

Authors:  Xiaosong Li; Min Min; Nan Du; Ying Gu; Tomas Hode; Mark Naylor; Dianjun Chen; Robert E Nordquist; Wei R Chen
Journal:  Clin Dev Immunol       Date:  2013-03-04

8.  A Multiple siRNA-Based Anti-HIV/SHIV Microbicide Shows Protection in Both In Vitro and In Vivo Models.

Authors:  Sandhya Boyapalle; Weidong Xu; Payal Raulji; Subhra Mohapatra; Shyam S Mohapatra
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

Review 9.  Therapeutic Potency of Nanoformulations of siRNAs and shRNAs in Animal Models of Cancers.

Authors:  Md Emranul Karim; Kyi Kyi Tha; Iekhsan Othman; Mohammad Borhan Uddin; Ezharul Hoque Chowdhury
Journal:  Pharmaceutics       Date:  2018-05-26       Impact factor: 6.321

Review 10.  Cell Penetrating Peptides as Molecular Carriers for Anti-Cancer Agents.

Authors:  Antonella Borrelli; Anna Lucia Tornesello; Maria Lina Tornesello; Franco M Buonaguro
Journal:  Molecules       Date:  2018-01-31       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.